Nine months highlights1
Continuing operations results2:
- DSM reports a solid first nine months in a challenging COVID-19 environment, with a continuing robust performance in Q3, despite significant negative foreign exchange effects
- Group sales stable and Adjusted EBITDA -3%
- Nutrition: sales +4%, organic sales +5%, Adjusted EBITDA +6%
- Materials: sales -18%, volumes -13%, Adjusted EBITDA -33%
- Adjusted net profit down 8% to €544m
Total Group:
- Net profit: €453m
- Adjusted Net Operating Free Cash Flow of €639m, up 16% year to date
- Outlook 2020 unchanged
Key figures and indicators – continuing operations2
in € million | Jan-Sept 2020 | Jan-Sept 2019 | % Change | Volume | Price/mix | FX | Other |
Sales | 6,026 | 6,064 | -1% | 1% | -1% | -2% | 1% |
Nutrition | 4,771 | 4,573 | 4% | 5% | 0% | -3% | 2% |
Materials | 1,092 | 1,327 | -18% | -13% | -5% | -1% | 1% |
Adjusted EBITDA | 1,144 | 1,178 | -3% |
|
|
|
|
Nutrition | 1,014 | 956 | 6% |
|
|
|
|
Materials | 187 | 278 | -33% |
|
|
|
|
Innovation | 16 | 19 |
|
|
|
|
|
Corporate | -73 | -75 |
|
|
|
|
|
EBITDA | 1,020 | 1,133 |
|
|
|
|
|
Adjusted EBITDA margin | 19.0% | 19.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Adjusted EBITDA is an Alternative Performance Measure (APM) that reflects continuing operations. | |||||||
Organic sales growth is the total impact of volume and price/mix. | |||||||
| Adjusted Net Operating Free Cash Flow is the cash flow from operating activities, corrected for the cash flow of the APM adjustments, minus the cash flow of capital expenditures and drawing rights. | |||||||
| 2 Results excluding business held for sale | |||||||
